Literature DB >> 1511118

A study of cervical cancer in Ethiopian women.

A Pelzer1, M E Duncan, G Tibaux, L Mehari.   

Abstract

In common with many African countries, Ethiopia has a very limited cytological service, smears are only taken in a hospital or clinic setting and until very recently most had to be sent abroad for analysis. We describe the results of a clinical and cytological investigation of 2111 women attending hospitals and clinics in Addis Ababa: 33 invasive or microinvasive cancers and 10 dysplasias (CIN) were detected. The prevalence of invasive cervical cancer in that population was 15.6/1000. Risk factors were shown to be age over 35 (especially over 50), parity over six (especially more than 10), very low income or subsistence economy, particularly in those from the rural areas, and prostitution. Less significant factors, possibly related to age, were sexual activity of more than 20 years and first coitus before the age of 15; and more than five sexual partners. Most (66%) of women with invasive cancer were at stage 3 or 4.

Entities:  

Mesh:

Year:  1992        PMID: 1511118     DOI: 10.1111/j.1365-2303.1992.tb00039.x

Source DB:  PubMed          Journal:  Cytopathology        ISSN: 0956-5507            Impact factor:   2.073


  3 in total

1.  Survival status and associated factors of death among cervical cancer patients attending at Tikur Anbesa Specialized Hospital, Addis Ababa, Ethiopia: a retrospective cohort study.

Authors:  Mulugeta Wassie; Zeleke Argaw; Yosief Tsige; Mesfin Abebe; Sezer Kisa
Journal:  BMC Cancer       Date:  2019-12-16       Impact factor: 4.430

2.  Patient side cost and its predictors for cervical cancer in Ethiopia: a cross sectional hospital based study.

Authors:  Alemayehu Hailu; Damen Haile Mariam
Journal:  BMC Cancer       Date:  2013-02-08       Impact factor: 4.430

3.  Precancerous cervical lesion in Ethiopia: systematic review and meta-analysis.

Authors:  Ayele Semachew Kasa; Tadesse Dagget; Yeshiwork Beyene; Getnet Dessie; Aklilu Endalamaw; Yinager Workineh; Emiru Ayalew; Balew Zeleke; Sitotaw Kerie; Getasew Mulat; Worku Animaw
Journal:  Syst Rev       Date:  2021-11-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.